Oncolytics Biotech (TSE:ONC) Stock Passes Above Two Hundred Day Moving Average – Here’s What Happened

Oncolytics Biotech Inc. (TSE:ONC) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$1.40 and traded as high as C$1.42. Oncolytics Biotech shares last traded at C$1.41, with a volume of 199,488 shares changing hands.

Wall Street Analyst Weigh In

Separately, Raymond James raised shares of Oncolytics Biotech to a “moderate buy” rating in a research note on Thursday, November 14th.

Oncolytics Biotech Stock Performance

The stock has a 50 day moving average of C$1.42 and a 200 day moving average of C$1.40. The company has a market capitalization of C$109.91 million, a price-to-earnings ratio of -3.76 and a beta of 1.35. The company has a quick ratio of 8.86, a current ratio of 4.99 and a debt-to-equity ratio of 6.09.

About Oncolytics Biotech

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.